Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Paul Funk II, a director at Red Cat Holdings, Inc. (NASDAQ:RCAT), executed a significant divestment of company shares on June 11, 2026. The transaction involved the sale of 165,028 shares, generating proceeds of approximately $1,897,822. This sale occurred as Red Cat Holdings continues to expand its operational footprint in the defense drone sector…
Jay M. Moyes, a director at Puma Biotechnology, Inc. (NASDAQ:PBYI), sold 22,000 shares for $158,796 on June 12, 2026, under a 10b5-1(c) plan. This sale occurred shortly after he received 27,000 RSU shares and amidst a challenging first-quarter 2026 earnings report that missed analyst expectations for both revenue and net income. The transaction hig…
Gerhard Watzinger, a director at CrowdStrike Holdings, Inc. (NASDAQ:CRWD), recently executed a significant divestment of company stock, selling approximately $1.71 million worth of shares in mid-June 2026. This transaction, filed with the Securities and Exchange Commission, highlights executive-level portfolio adjustments against a backdrop of robu…
Gevo, Inc. (NASDAQ:GEVO) President and COO Ryan Christopher Michael executed a sale of 35,196 shares of common stock on June 12, 2026, totaling $50,161. The transaction was conducted under a pre-arranged 10b5-1 trading plan established in November 2025 to fulfill tax withholding obligations linked to the vesting of a restricted stock award. Followi…
Brian M. Stuglik, a director at Puma Biotechnology, Inc. (NASDAQ:PBYI), sold 8,100 shares of the company’s common stock for a total of $58,311 on June 12, 2026. The transaction was conducted under a pre-arranged 10b5-1 trading plan, which was adopted on March 12, 2025. The sale followed an acquisition of 27,000 shares of common stock by Mr. Stuglik…
Adrian Senderowicz, a director at Puma Biotechnology, Inc. (NASDAQ:PBYI), has executed a sale of 27,000 shares of common stock valued at $194,310 on June 12, 2026, according to a Securities and Exchange Commission filing. The transaction was conducted under a pre-established Rule 10b5-1 trading plan adopted on March 12, 2025. This sale immediately …
Century Therapeutics, Inc. (NASDAQ: IPSC) reported a recent insider transaction involving Senior Vice President of Finance and Operations Douglas Carr, who disposed of 1,654 shares on June 12, 2026. The sale, valued at $3,691, was executed at $2.232 per share and was not discretionary, serving to cover tax withholding obligations tied to the vestin…
Oil prices recovered modestly in Asian trade after a near 5% drop left benchmarks at three-month lows. Traders are awaiting details on a U.S.-Iran memorandum of understanding that aims to reopen the Strait of Hormuz, while questions about maritime security, insurance costs and the pace of restoring flows keep uncertainty elevated.
U.S. stock futures edged lower Monday evening after a strong session that followed news of a U.S.-Iran memorandum of understanding to end hostilities and renewed momentum in technology stocks. Traders remained cautious ahead of a two-day Federal Reserve meeting expected to conclude with unchanged interest rates, while markets also awaited the forma…
Allison Dorval, a director at PUMA BIOTECHNOLOGY, INC. (NASDAQ:PBYI), has executed a series of significant share transactions, selling 11,610 shares for $83,579 under a pre-arranged 10b5-1 trading plan. This activity follows her acquisition of 27,000 restricted stock units on the preceding day. The insider movement occurs against a backdrop of a 10…
Comstock Inc. director Steven Pei increased his indirect ownership in the company through two separate transactions in mid-June 2026, bringing his total holdings to 1,868,323 shares. The acquisitions were executed through Gratia Capital and coincide with a period of significant stock price recovery for LODE. The company also recently finalized a tr…
Gregory Russotti, serving as the Chief Technology and Manufacturing Officer at Century Therapeutics, Inc. (NASDAQ: IPSC), executed a transaction involving the sale of 2,584 shares of the company's common stock on June 12, 2026. The total value of the sale was $5,767, with each share transacted at a price of $2.232. This activity was necessitated by…
Dawn Christine Maroney, president of Alignment Healthcare Inc. (NASDAQ: ALHC), sold 30,000 shares of the company’s common stock on June 15, 2026, under a pre-arranged Rule 10b5-1 trading plan. The transaction, valued at $586,425, brings her direct holdings to 947,313 shares. This sale follows a period of strong financial performance for the company…
Sonida Senior Living, Inc. (NASDAQ:SNDA) director Benjamin P. Harris executed a direct sale of 2,500 shares on May 13, 2026, totaling $93,654 at a price of $37.4618 per share. This transaction leaves Harris with a remaining direct holding of 9,182 shares. The sale occurred as SNDA shares traded at $34.58, below the transaction price, despite the st…
Itron, Inc. announced a significant collaboration with Watercare Services, New Zealand's largest water utility, to upgrade 100,000 mechanical water meters to Itron Intelis wSource digital meters in Auckland. This large-scale smart meter deployment is expected to improve leak detection, billing accuracy, and operational efficiency, supporting Waterc…
Lawrence Klein, Chief Executive Officer of Oruka Therapeutics, Inc. (NASDAQ: ORKA), executed a sale of 1,729 shares of the company's common stock, totaling $120,494. The transaction, reported on June 15, 2026, was facilitated through an automatic, non-discretionary "sell-to-cover" procedure designed to meet tax withholding obligations associated wi…
Abeona Therapeutics Inc. (NASDAQ: ABEO) director Christine Berni Silverstein executed a sale of 18,160 shares on June 15, 2026, valued at $103,695. The transactions, priced between $5.68 and $5.73 per share, were undertaken to satisfy tax liabilities linked to vesting restricted stock awards. Following the sale, Silverstein retains a direct positio…
StoneX Group Inc. (NASDAQ: SNEX) Chief Financial Officer William J. Dunaway executed a significant divestment of company stock on June 12, 2026, selling 63,602 shares valued at approximately $8.34 million. The transaction occurred against a backdrop of robust stock performance, strong earnings per share results, and a newly approved three-for-two s…
Yorkville International Capital Corp. has priced an initial public offering of 20,000,000 units at $10.00 apiece, raising $200 million. The units are scheduled to begin trading on the Nasdaq Global Market under the ticker YICCU on June 16, 2026, and the offering is expected to close on June 17, 2026, subject to customary closing conditions. Each un…
Yorkville International Capital Corp. priced its initial public offering of 20 million units at $10 each, expected to list on Nasdaq under ticker YICCU. Each unit includes one Class A ordinary share and one-third warrant, with full warrants exercisable at $11.50. The company, a Cayman Islands-incorporated blank check firm, aims to pursue business c…
Vincent P. Pangrazio, who serves as Executive Vice President, Chief Legal Officer, and Corporate Secretary at SiTime Corporation (NASDAQ: SITM), executed a sale of company shares on June 12, 2026. The transaction involved the disposal of 2,000 shares at $725.32 each, resulting in total proceeds of approximately $1,450,640. This activity follows a p…
Lionel Bonnot, Executive Vice President of Worldwide Sales and Business Development at SITIME Corp (NASDAQ:SITM), executed multiple sales totaling $1,068,010 in company common stock on June 11 and June 15, 2026. The transactions involved the disposal of 1,500 shares at prices ranging from $700.00 to $736.02 per share. Following these sales, Bonnot …
Rajesh Vashist, Chief Executive Officer of SITIME Corp. (NASDAQ:SITM), executed a significant divestment of company shares on June 15, 2026. The executive sold a total of 20,000 shares, generating an aggregate transaction value of $15,003,000. This activity occurs as SITM shares trade at $743.14, following a substantial 253% return over the past ye…
Lam Research Corp (NASDAQ:LRCX) director Eric Brandt executed a significant divestment of company equity on June 12, 2026, selling 54,500 shares for a total value of $20,011,345. The transaction was facilitated through a Rule 10b5-1 trading plan established earlier in the year. This sale reduces Brandt’s direct holdings, which include unvested rest…
SITIME Corp director Raman Chitkara executed a transaction to sell 2,000 shares on June 12, 2026, realizing approximately $1.45 million from the disposal. The sale occurs against a backdrop of significant stock appreciation and recent positive financial reporting from the company. Chitkara retains a smaller direct stake in the corporation following…
